☆ 4.8 Article

Study on liver histopathology of chronic HBV infected patients with different normal ALT values

FRONTIERS IN IMMUNOLOGY (2022)

Related references

Note: Only part of the references are listed.

Review Biochemistry & Molecular Biology

Hepatitis B Flare in Hepatitis B e Antigen-Negative Patients: A Complicated Cascade of Innate and Adaptive Immune Responses

Ming-Ling Chang et al.

Summary: Chronic hepatitis B virus (HBV) infection is a complex process involving interactions among HBV, hepatocytes, and the host immune system. Hepatitis B flares can occur in both HBeAg-positive and HBeAg-negative patients, and the clinical manifestations vary. This review focuses on the management of HBV flares in HBeAg-negative chronic hepatitis B (CHB) patients and provides insight into the immunopathogenesis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Gastroenterology & Hepatology

Should Treatment Indications for Chronic Hepatitis B Be Expanded?

Wen-Juei Jeng et al.

Summary: Current treatment for chronic hepatitis B virus (HBV) does not eradicate the virus, requiring long-term maintenance for most patients. Expanding treatment to certain patient populations, such as immune tolerant patients and those with evidence of liver disease, is supported by available evidence. However, data supporting treatment expansion for confirmed inactive carriers and other immune tolerant patients is lacking. New therapies that can achieve HBsAg loss in a high percentage of patients after a finite course of treatment may allow for more liberal HBV treatment indications in the future.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Add to Collection

Article Virology

Early Serum HBsAg Kinetics as Predictor of HBsAg Loss in Patients with HBeAg-Negative Chronic Hepatitis B after Treatment with Pegylated Interferonα-2a

Minghui Li et al.

Summary: The study showed that HBsAg levels at 12 and 24 weeks could predict HBsAg loss at 96 and 120 weeks in HBeAg-negative CHB patients, with better predictive ability at 24 weeks compared to 12 weeks.

VIROLOGICA SINICA (2021)

Add to Collection

Article Gastroenterology & Hepatology

Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy

Xiao-Yan Jiang et al.

Summary: The study observed the long-term outcomes of chronic hepatitis B patients without antiviral treatment and found that both antiviral therapy and non-antiviral therapy with liver protection and anti-inflammatory therapy can reduce the risk of hepatocellular carcinoma (HCC). However, antiviral therapy may mask the spontaneous serological response of some CHB patients, making early antiviral therapy crucial in reducing the incidence of HCC.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Immunological measurement of aspartate/alanine aminotransferase in predicting liver fibrosis and inflammation

Hyun Jeong Kim et al.

KOREAN JOURNAL OF INTERNAL MEDICINE (2020)

Add to Collection

Review Gastroenterology & Hepatology

Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad

Marc G. Ghany et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase

Han Ah Lee et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

Add to Collection

Article Gastroenterology & Hepatology

Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection

Mayur Brahmania et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Norah A. Terrault et al.

HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

JOURNAL OF HEPATOLOGY (2017)

Add to Collection

Article Immunology

Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China

Fuqiang Cui et al.

EMERGING INFECTIOUS DISEASES (2017)

Add to Collection

Article Gastroenterology & Hepatology

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

S. K. Sarin et al.

HEPATOLOGY INTERNATIONAL (2016)

Add to Collection

Article Gastroenterology & Hepatology

Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia

C. Rinaldi A. Lesmana et al.

JOURNAL OF DIGESTIVE DISEASES (2011)

Add to Collection

Article Gastroenterology & Hepatology

Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT

Manoj Kumar et al.

GASTROENTEROLOGY (2008)

Add to Collection

Article Gastroenterology & Hepatology

Chronic hepatitis B virus carriers in the immunotolerant phase of infection:: Histologic findings and outcome

Tony Andreani et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.